ROCKVILLE, Md.--(BUSINESS WIRE)--SYNAPS Dx (SDx) a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer’s disease (AD), recognizes the ...

SAN FRANCISCO & BALTIMORE--(BUSINESS WIRE)--W2O, the leading independent provider of analytics-driven, technology-enabled marketing and communications solutions to the healthcare sector, today ...

W2O has bought US health economics and outcomes research company Discern Health, marking its sixth acquisition in less than a year. The move will give Discern Health access to healthcare ...

Worldwide, organisations invested more than $150 billion in cybersecurity products and services last year according to the consultant McKinsey, 12% more than a year previously. So why do the number of ...

Information currently available to the public is inadequate to support those deciding to consent to a genetic test. As genetic knowledge continues to evolve, more people will be forced to consider the ...